BENDER ROBERT & ASSOCIATES
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 894300
PASADENA, CA
Position in VRTX
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$11,686,398
-$310,867 QoQ
Shares Held
26,171
-1.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
2.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$12,790,431
PutShares
27,288
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BENDER ROBERT & ASSOCIATES holds $12,310,321 across 2 Biotechnology names. VRTX ranks #1 (94.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
26,171 | $11,686,398 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
34,701 | $623,923 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,686,398 | 26,171 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $11,997,265 | 26,463 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $10,311,881 | 26,330 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $11,892,182 | 26,712 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $13,102,260 | 27,025 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $10,996,126 | 27,306 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,619,480 | 27,134 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $12,790,431 | 27,288 | Put | Sole | 2024-07-30 | |
| 2024-03-31 | $11,776,177 | 28,172 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $11,616,709 | 28,550 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $9,894,593 | 28,454 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $9,996,707 | 28,407 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $9,085,673 | 28,837 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $8,333,902 | 28,859 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $8,354,387 | 28,854 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $7,938,306 | 28,171 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $7,422,508 | 28,442 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $6,612,156 | 30,110 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,461,652 | 30,110 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,126,124 | 30,383 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $6,477,859 | 30,145 | Shares | Sole | 2021-04-28 | |
| No filing history on record for this holder in this stock. | ||||||